Study Emphasizes PSMA PET Staging of High-Risk, Hormone Sensitive Prostate Cancer
Diagnostic Imaging
JANUARY 4, 2025
In patients with high-risk, hormone sensitive prostate cancer who had no evidence of metastasis on conventional imaging, PSMA PET revealed polymetastatic disease in 24 percent of patients and M1 disease staging in 46 percent of patients.
62 
Let's personalize your content